‘Version 2.0’ of UQ COVID-19 vaccine to start clinical trials in 2022

However, the actual clamp molecule used was sourced from the HIV virus because it was very effective and the researchers didn’t have time to look for a better candidate.

Although there was no risk of contracting HIV from the small molecule, it did set off HIV screening tests, something the…